[1] BEPLER G,BEQUM M,SIMON G R. Molecular analysis-based treatment strategies for non-small cell lung cancer[J].Cancer Control,2008,15(2):130-139. [2] 魏雨晴,吕镗烽,刘红兵,等.肺癌分子诊断及其研究进展[J].中国实用内科杂志,2019,39(5):407-411. [3] GOVINDAN R, PAGE N, MORGENSZTERN D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years:analysis of the surveillance, epidemiologic, and end results database[J]. J Clin Oncol, 2006,24(28):4539-4544. [4] JETT J R, SCHILD S E, KESLER K A, et al. Treatment of small cell lung cancer:Diagnosis and management of lung cancer, 3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest, 2013,143(5 Suppl):e400S-e419S. [5] JEREMIC B, SHIBAMOTO Y, NIKOLIC N,et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer:A randomized study[J]. J Clin Oncol,1999,17(7):2092-2099. [6] PODOLOFF D A, BALL D W, BEN-JOSEF E, et al. NCCN task force:clinical utility of PET in a variety of tumor types[J]. J Natl Compr Canc Netw, 2009,7(Suppl 2):S1-S26. [7] BRADLEY J D, DEHDASHTI F, MINTUN M A, et al. Positron emission tomography in limited-stage small-cell lung cancer:a prospective study[J]. J Clin Oncol, 2004,22(16):3248-3254. [8] FISCHER B M, MORTENSEN J, LANGER S W,et al. A prospective study of PET/CT in initial staging of small-cell lung cancer:comparison with CT, bone scintigraphy and bone marrow analysis[J]. Ann Oncol, 2007,18(2):338-345. [9] KALEMKERIAN G P. Staging and imaging of small cell lung cancer[J]. Cancer Imaging, 2011,11(1):253-258. [10] MAMDANI H, INDURU R, JALAL S I. Novel therapies in small cell lung cancer[J]. Transl Lung Cancer Res,2015,4(5):533-544. [11] CUI X, SONG P, ZHANG L. New advances in the treatment for small cell lung cancer[J]. Zhongguo Fei Ai Za Zhi, 2019,22(6):355-362. [12] HAN B H, LI K, WANG Q M, et al. Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer:the ALTER 0303 phase 3 randomized clinical trial[J]. JAMA Oncol,2018,4(11):1569-1575. [13] YANG S, ZHANG Z, WANG Q. Emerging therapies for small cell lung cancer[J]. J Hematol Oncol,2019,12(1):47. [14] HAMMING L C, SLOTMAN B J, VERHEUL H M W,et al. The clinical application of angiostatic therapy in combination with radiotherapy:past, present, future[J]. Angiogenesis. 2017,20(2):217-232. [15] DINGS R P, LOREN M, HEUN H,et al. Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization[J]. Clin Cancer Res,2007,13(11):3395-3402. [16] JAIN R K. Molecular regulation of vessel maturation[J]. Nat Med,2003,9(6):685-693. [17] JAIN R K.Normalization of tumor vasculature:an emerging concept in antiangiogenic therapy[J]. Science,2005,307(5706):58-62. [18] MATSUMOTO S, BATRA S, SAITO K, et al.Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia[J]. Cancer Res,2011,71(20):6350-6359. [19] GUPTA V K, JASKOWIAK N T, BECKETT M A,et al. Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance[J]. Cancer J,2002, 8(1):47-54. [20] GARCIA-BARROS M, PARIS F, CORDON-CARDO C,et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis[J]. Science,2003,300(5622):1155-1159. |